据了解,这种食品酶是田a href='//www.sqrdapp.com/news/tag_2434.html' class='zdbq' title='转基因相关食品资? target='_blank'>转基囟/a>
米曲霈/a>菌株AR-183生产的,旨在用于七种食品生产过程、/div>
经过评估,专家小组得出结论,这种食品酶在预期使用条件下不会引起安全问题。部分原文报道如下:
The food enzyme endo-polygalacturo
nase ((1??4)--d-galacturo
nan glycanohydrolase EC 3.2.1.15) is produced with the genetically modified Aspergillus oryzae strain AR-183 by AB ENZYMES GmbH. A safety e
valuation of this food enzyme was made previously, in which EFSA co
ncluded that this food enzyme did not give rise to safety co
ncerns when used in five food manufacturing processes. Subsequently, the applicant requested to extend its use to two additio
nal processes. In this assessment, EFSA updat
ed the safety e
valuation of this food enzyme for use in a total of seven food manufacturing processes. As the food enzyme-total organic solids (TOS) is removed from the final foods in three food manufacturing processes, the dietary exposure to the food enzyme-TOS was estimated o
nly for the remaining four processes. Dietary exposure was up to 0.087 mg TOS/kg body weight (bw) per day in European populations. When combined with the NOAEL reported in the previous opinion (1000 mg TOS/kg bw per day, the highest dose tested), the Panel derived a margin of exposure of at least 11,494. ba
sed on the data provided for the previous e
valuation and the revised margin of exposure, the Panel co
ncluded that this food enzyme does not give rise to safety co
ncerns under the revised intended co
nditions of use.
本文由食品伙伴网食品资讯中心编辑,供网友参考,有任何疑问,请联系news@www.sqrdapp.com、/span>